Nanobio and Nanomedicine

Cell's nano sized technology is a low density emulsion, named LDE, with particles similar to the structure of low-density lipoprotein (LDL) which acquires the apo E while in the plasma, thus becoming capable of targeting and binding to the specific receptors of LDL existing on the surface of cellular membranes.

iCeutica has developed the Encapsulated Organic Nanoparticles (EON™) Platform to produce consistent nano-sized drug particles.

IGI offers its proprietary Novasome lipid vesicle encapsulation technology for use in delivering solutions to the dermatological, consumer, skin care and hair care markets. Apart from Novasome, IGI uses proprietary organized lipid structures, cellulose structures and micellar nanoparticles.

The company's SonoLysis program is focused on the development of two product candidates that involve the administration of proprietary MRX-801 micro- and nanobubbles and ultrasound with or without a thrombolytic drug to break up blood clots and restore blood flow to oxygen deprived tissues.

Developed and integrated several patented technologies for the isolation, manipulation and analysis of rare cells. Patented magnetic nanoparticles, called ferrofluids, are at the heart of rare cell isolation for their kits and marker reagents.

(German language site) The company is a Contract Research Organisation for the development and improvement of advanced cell culture systems for industrial drug screening applications, biomaterial testing and pharma-toxicological research.

Inanovate creates nano-scale surface structures through a unique and proprietary process capable of nano-meter precision in a time and cost effective way. Leveraging this unique platform and expertise, Inanovate is developing nano-structured biochip substrates to facilitate the next generation in biochip technology.

The company has active internal drug discovery programs focused on the identification of novel small molecule drugs for oncology, inflammation, HIV and diabetes.

Offers different microfluidic platforms that precisely manipulate different combinations of fluids to obtain jets, emulsions, bubbles, drops and particles in the nano and micrometric range.

The company's lead product in development is Amorphous Nano-Hydroxyapaite Powder. Nano-structured hydroxyapatite has several advantages over hydroxyapatite of larger particle size in its use in bone tissue engineering due to its higher surface area and consequently higher reactivity, which offers better cellular response. In addition, nano-sized hydroxyapatite is useful as an effective surface modification agent for binding numerous biological molecules.

Develops a nanoparticle mediated drug delivery system to solid tumors.

The foundation of the company's IVEC™ drug delivery platform is based on polymer micelle technology, spherical nanosized capsules formed by the assembly of block copolymers in water.

Develops a nanoparticle-based siRNA targeting the VEGF (Vascular Endothelial Growth Factor) pathwayas part of its RNA interference (RNAi) therapeutics for the treatment of human diseases.

Develops and markets a nanoparticle vector technology that combines DNA with the lipids DOTAP and cholesterol to create a synthetic gene delivery vehicle.

Invitek is a worldwide acting provider of innovative, high-quality solutions and technical support to the life sciences industry with two divisions operating in Genomics and Proteomics. The company offers a broad spectrum of superior products for molecular diagnostics, drug discovery and biomedical research.

Molecular probes and nano conjugates.

Iris Biotechnologies is dedicated to the development of Nano-Biochip gene expression kits to assist in establishing a solid and reliable foundation for personalized medicine. The company's patented products were developed to overcome the sensitivity, specificity, speed and cost limitations of present state-of-the-art microarray technology.

Develops scientific instrumentation and software for biomolecular and cellular bio applications including submicron analytical devices.